EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access

Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children

Ho-Chang Kuo, Xing Xue, Fang Liu, Richard D Mortensen, C James Chou, Bo Jin, Juan Wei, Qiong Luo, Ken-Pen Weng, Mindy Ming-Huey Guo, Kuender D Yang, Kuo-Jung Su und 13 weitere

JAMA Network Open · 28.05.2026 · 9 (5) · e2615420

DOI: 10.1001/jamanetworkopen.2026.15420 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Network Open, online erschienen am 28.05.2026. Verfasst von Ho-Chang Kuo und 24 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome, Fever. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Kawasaki disease (KD) remains a clinical diagnosis without an objective molecular test. Early identification is critical to prevent coronary artery complications through timely intravenous immunoglobulin therapy.

Objective

To validate a 2-gene whole-blood quantitative polymerase chain reaction (qPCR) assay measuring IFI27 and MCEMP1 expression for distinguishing KD from other pediatric febrile illnesses. Design, Setting, and Participants This multicenter diagnostic study was conducted in Taiwan and Shanghai, China. Patient blood samples were collected prospectively between 2012 and 2023 in Taiwan and between 2022 and 2023 in Shanghai and analyzed retrospectively from children younger than 8 years with KD and febrile controls (FCs) with viral, bacterial, or mixed infections. Data were analyzed from January 2022 to August 2025. Main Outcomes and Measures Diagnostic accuracy of a prespecified 2-gene KD score derived from change in cycle threshold values normalized to glyceraldehyde 3-phosphate dehydrogenase, assessed by area under the receiver operating characteristic curve (AUC), sensitivity, specificity, predictive values, and likelihood ratios.

Results

A total of 541 children (mean [SD] age, 3.7 [1.9] years; 300 [55.5%] male), including 243 children with KD and 298 febrile controls, were analyzed. The KD score achieved an AUC of 0.91 (95% CI, 0.88-0.94), with a sensitivity of 94% (95% CI, 93%-97%) and a specificity of 82% (95% CI, 78%-86%). The positive likelihood ratio was 5.12, and the negative likelihood ratio was 0.05. Performance was consistent across cohorts, including incomplete KD, diverse FC etiologies, and coronary artery phenotypes. The assay was implemented as a laboratory-developed test. Analytical validation demonstrated high linearity ( R 2 > 0.99), precision (coefficient of variation <5%), and sample stability for up to 6 days at 4 °C or for 24 hours at room temperature. Conclusions and Relevance This diagnostic study found that a 2-gene laboratory-developed whole-blood qPCR assay measuring IFI27 and MCEMP1 expression accurately distinguished KD from other febrile illnesses using standard molecular platforms. Prospective evaluation in broader populations is warranted to determine its clinical utility for reducing diagnostic delay and coronary complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucocutaneous Lymph Node SyndromeFeverHumansMaleFemaleChild, PreschoolSensitivity and SpecificityChinaTaiwanInfantRetrospective Studies

Autor:innen und Institutionen

  • College of Medicine Chang Gung University, Taoyuan, Taiwan.
  • Kawasaki Disease Center and Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
  • Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Heart Center, Children's Hospital of Fudan University, Shanghai, China.
  • OncoOmicsDx Clinical Laboratory, Rockville, Maryland.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Kuo, H. C., Xue, X., Liu, F., Mortensen, R. D., Chou, C. J., Jin, B., Wei, J., Luo, Q., Weng, K. P., Guo, M. M., Yang, K. D., Su, K. J., Kang, S. T., Kim, S., Li, W., Schilling, J., Han, Z., Ozawa, N., Ichikawa, T., …, & Ling, X. B. (2026). Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children. JAMA Network Open, 9(5), e2615420. https://doi.org/10.1001/jamanetworkopen.2026.15420

Vancouver

Kuo HC, Xue X, Liu F, Mortensen RD, Chou CJ, Jin B, et al. Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children. JAMA Network Open. 2026;9(5):e2615420. doi:10.1001/jamanetworkopen.2026.15420

BibTeX
@article{Kuo2026,
  author = {Kuo, Ho-Chang and Xue, Xing and Liu, Fang and Mortensen, Richard D and Chou, C James and Jin, Bo and Wei, Juan and Luo, Qiong and Weng, Ken-Pen and Guo, Mindy Ming-Huey and Yang, Kuender D and Su, Kuo-Jung and Kang, Shih-Ting and Kim, Sun and Li, Weiwei and Schilling, James and Han, Zhi and Ozawa, Naoto and Ichikawa, Takumi and Chubb, Henry and Ceresnak, Scott R and Darmstadt, Gary L and McElhinney, Doff and Cohen, Harvey J and Ling, Xuefeng B},
  title = {Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {5},
  pages = {e2615420},
  doi = {10.1001/jamanetworkopen.2026.15420}
}
Kostenlos starten →